Perform Necrotic Cavity Lavage or Not After Debridement of Infected Pancreatic Necrosis
NCLAD
A Randomized Controlled Trials on the Effect of Necrotic Cavity Lavage After Laparoscope-assisted Debridement for Patients With Infected Pancreatic Necrosis
1 other identifier
interventional
112
1 country
1
Brief Summary
The infected pancreatic necrosis (IPN) should be treated by debridement and drainage. In recent years, the results of clinical research show that minimally invasive debridement such as video-assisted (laparoscope, nephroscope, endoscopy, etc.) and total laparoscopic debridement can significantly improve the prognosis of IPN patients. After a long period of clinical practice, laparoscope-assisted debridement was selected as the main surgical method in our center. In many large-scale clinical studies, patients after surgery underwent necrotic cavity lavage (such as small omental sac lavage, retroperitoneal space lavage, peripancreatic lavage, etc.), but its necessity and clinical significance were not clearly stated in the guidelines. At present, the clinical research mainly focuses on the improvement of minimally invasive debridement, and less on the necessity of lavage. In the past, necrotic cavity lavage was performed in IPN patients, but long-term clinical observation showed that lavage may lead to spread of infection and increase the incidence of lower extremity venous thrombosis which is not accorded with ERAS(Enhanced Recovery After Surgery). Therefore, since 2012, our center has stopped necrotic cavity lavage for IPN patients after debridement. We retrospectively analyzed the therapeutic effect from February 2014 to August 2017 and found that even without necrotic cavity lavage, better therapeutic effect could be achieved. Meanwhile it can simplify the operation process and avoid infection spread. This treatment method provides a new idea. However, it is a retrospective study not a randomized controlled trials(RCT) which is low effectiveness of proof. Therefore, we design this RCT to verify the necessity of necrotic cavity lavage after laparoscope-assisted debridement for patients with infected pancreatic necrosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 12, 2020
CompletedFirst Posted
Study publicly available on registry
February 19, 2020
CompletedStudy Start
First participant enrolled
June 12, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 12, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 12, 2021
CompletedJune 18, 2020
February 1, 2020
1 year
February 12, 2020
June 16, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
sum rate of mortality and major complications
number of deaths and major complications (new organ failure or intraperitoneal hemorrhage/gastrointestinal fistula requiring surgical treatment)/total enrollment
1 year
Secondary Outcomes (10)
physiological parameter
through study completion, an average of 2 months
physiological parameter
through study completion, an average of 2 months
assay index
through study completion, an average of 2 months
assay index
through study completion, an average of 2 months
assay index
through study completion, an average of 2 months
- +5 more secondary outcomes
Study Arms (2)
necrotic cavity lavage
EXPERIMENTALThis arm was performed necrotic cavity lavage after debridement
non-necrotic cavity lavage
NO INTERVENTIONThis arm was not performed necrotic cavity lavage after debridement
Interventions
1. At least two 30- to 36-Fr drainage tubes will be placed into each necrotic cavity. One of these drainage tubes will be used as the lavage tube; the other tube is designed for drainage. 2. Lavage will begin on the first day after debridement, and the relevant indices will be evaluated every 7 days to decide whether to continue the lavage. 3. 1200 mL of normal saline will be lavaged into each necrotic cavity every day at a speed of 200 mL/h for 3 hours each time and for a total of two times. The start times of lavage will be 08:00 and 20:00. 4. The lavage and drainage volumes of the first hour and second hour of each lavage session will be calculated. The lavage of the next hour will be stopped if the lavage volume minus the drainage volume is \>100 mL. 5. Lavage will be suspended if abdominal pain and distention occur, the maximum body temperature is \>38.5ºC, or the abdominal pressure is ≥15 mmHg during the lavage procedure.
Eligibility Criteria
You may qualify if:
- diagnosis of IPN
- onset time of \>4 weeks
- performance of LAD for IPN
- provision of written informed consent
You may not qualify if:
- the highest temperature in 24 hours of ≥38.5ºC
- new organ failure occurring within 24 hours after the operation
- digestive tract fistula, biliary tract or digestive tract obstruction, or bleeding occurring within 24 hours after the operation
- abdominal pressure of ≥10 mmHg within 24 hours after the operation
- traumatic pancreatitis or a pancreatic fistula-related infection after the pancreatic operation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Xuanwu hospital Capital Medical University
Beijing, Beijing Municipality, 100053, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Fei Li, MD
Xuanwu Hospital, Beijing
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 12, 2020
First Posted
February 19, 2020
Study Start
June 12, 2020
Primary Completion
June 12, 2021
Study Completion
October 12, 2021
Last Updated
June 18, 2020
Record last verified: 2020-02
Data Sharing
- IPD Sharing
- Will not share